|
|
|
Volumn 145, Issue 5, 2003, Pages 9-
|
|
In high risk patients cyclooxygenase inhibitor plus proton pump inhibitor;Bei Hochrisikopatienten Coxibe plus Protonenpumpenhemmer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIULCER AGENT;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
FIBRINOLYTIC AGENT;
ISOENZYME;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PROTON PUMP;
PTGS2 PROTEIN, HUMAN;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CORONARY ARTERY DISEASE;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
DRUG INTERACTION;
HUMAN;
PEPTIC ULCER BLEEDING;
RHEUMATOID ARTHRITIS;
RISK FACTOR;
STOMACH ULCER;
ANTI-ULCER AGENTS;
ARTHRITIS, RHEUMATOID;
ASPIRIN;
CORONARY DISEASE;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
FIBRINOLYTIC AGENTS;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
PEPTIC ULCER HEMORRHAGE;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PROTON PUMPS;
RISK FACTORS;
STOMACH ULCER;
|
|
EID: 0038179434
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
